Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Phosphorylated AktSer473 expression between BCSCs and non-BCSCs from primary human breast cancer specimens

From: The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors

  Expression level of p-AktSer473 (%, MFI)a
  BCSCs (CD45-CD24-CD44+) Non-BCSCs (other populations of CD45- cells) Ratiob (BCSCs/non-BCSCs)
BC0414 33.3 (9.7) 17.5 (9.4) 1.90
BC0417 41.8 (32.0) 29.0 (33.0) 1.44
BC0422 32.4 (16.9) 14.3 (25.2) 2.27
BC0426 23.3 (5.2) 22.6 (5.7) 1.03
BC0450 41.3 (10.3) 56.2 (13.9) 0.73
BC0466 56.7 (36.5) 40.8 (44.1) 1.39
BC0480 55.7 (11.8) 37.8 (9.6) 1.47
BC0485 33.0 (44.2) 43.4 (54.8) 0.76
BC0512 57.8 (66.7) 37.8 (38.2) 1.53
BC0526 53.9 (28.2) 50.8 (34.4) 1.06
BC0533 47.8 (33.8) 0
  1. BSCS, breast cancer stem cell; MFI, mean fluorescence intensity ap-AktSer473 expression was determined by flow cytometry as described in Materials and methods. bThe ratio was calculated according to the positive percentage of pAktSer473 in BCSCs and non-BCSCs.